CYTK - Company ID 0001061983
The table below shows CYTOKINETICS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $19.36M | $1.94M | $66.77M | $1.58M | $463.00K | $249.00K |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $95.53M | $99.23M | $112.55M | $98.26M | $84.61M | $79.60M |
CYTOKINETICS INC reported annual revenue of $88.04M for fiscal year 2025. That is up 376.6% from $18.47M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $106.41M (FY 2016) to $88.04M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $104.90M |
| $69.46M |
| $65.72M |
| $57.37M |
| $56.65M |
| $50.82M |
| Operating income | -$183.62M | -$166.75M | -$111.51M | -$155.63M | -$140.80M | -$130.17M |
| Income tax | - | - | - | - | - | - |
| Net income | -$206.03M | -$306.18M | -$134.37M | -$161.38M | -$160.54M | -$143.32M |
| EPS (diluted) | -$1.67 | -$2.55 | -$1.12 | -$1.36 | -$1.36 | -$1.31 |